Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 18Hematologic Neoplasms 10Prostatic Neoplasms 9Colorectal Neoplasms 9Breast Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 8Carcinoma, Non-Small-Cell Lung 7Anatomic Stage I Breast Cancer AJCC v8 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Neoplasms 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Carcinoma 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Multiple Myeloma 3Melanoma 3Malignant Solid Neoplasm 3Lymphoma 3Leukemia, Myeloid, Acute 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Mouth Neoplasms 2Head and Neck Neoplasms 2

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2Etoposide 2Carboplatin 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Thiotepa 1Standard of Care 1Second-Look Surgery 1Respiratory Physiological Phenomena 1Reoperation 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cisplatin 1Bleomycin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Embryonal × Practice Guidelines as Topic × 1 year × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡